• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白的促线粒体毒性与 MAPK 激活有关,涉及到线粒体中 tau 的磷酸化和聚集。

Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria.

机构信息

Department of Immunology and Microbiology, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, United States; Department of Neuroscience, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, United States.

Palm Beach Gardens, FL 33418, United States.

出版信息

Neurobiol Dis. 2019 Apr;124:248-262. doi: 10.1016/j.nbd.2018.11.015. Epub 2018 Nov 22.

DOI:10.1016/j.nbd.2018.11.015
PMID:30472299
Abstract

We recently identified a truncated and phosphorylated form of α-synuclein, pα-syn*, as a key neurotoxic α-synuclein species found in cultured neurons, as well as in mouse and Parkinson's disease patients' brains. Small pα-syn* aggregates localize to mitochondria and induce mitochondrial damage and fragmentation. Herein, we investigated the molecular basis of pα-syn*-induced toxicity. By immunofluorescence, we found phosphorylated MKK4, JNK, ERK5 and p38 MAPKs in pα-syn* inclusions. pJNK colocalized with pα-syn* at mitochondria and mitochondria-associated ER membranes where it was associated with BiP and pACC1, markers for the ER and energy deprivation, respectively. We also found that pα-syn* aggregates are tightly associated with small ptau aggregates of similar size. Pα-syn*/ptau inclusions localized to areas of mitochondrial damage and to mitophagic vesicles, showing their role in mitochondrial toxicity, mitophagy induction and their removal along with damaged mitochondrial fragments. Several MAPKs may act cooperatively to phosphorylate tau, notably JNK, p38 and GSK3β, a non-MAPK that was also found phosphorylated in the vicinity of pα-syn*/ptau aggregates. These results add insight into the mechanisms by which pα-syn* exerts its toxic effects that include the phosphorylation of several kinases of the MAPK pathway, as well as the formation of ptau at the mitochondrial membrane, likely contributing to mitotoxicity. Thus pα-syn* appears to be the trigger of a series of kinase mediated pathogenic events and a link between α-syn pathology and tau, another protein known to aggregate in Parkinson's disease and other synucleinopathies.

摘要

我们最近发现了一种截断和磷酸化的α-突触核蛋白形式,即 pα-突触核蛋白*,它是在培养神经元以及在小鼠和帕金森病患者大脑中发现的关键神经毒性α-突触核蛋白物质。小的 pα-突触核蛋白聚集体定位于线粒体,并诱导线粒体损伤和碎片化。在此,我们研究了 pα-突触核蛋白-诱导毒性的分子基础。通过免疫荧光,我们发现磷酸化的 MKK4、JNK、ERK5 和 p38 MAPK 存在于 pα-突触核蛋白包含物中。pJNK 与 pα-突触核蛋白在线粒体和线粒体相关内质网膜上共定位,在那里它与 BiP 和 pACC1 相关,BiP 和 pACC1 分别是内质网和能量剥夺的标志物。我们还发现 pα-突触核蛋白聚集体与大小相似的小 ptau 聚集体紧密相关。pα-突触核蛋白/ptau 包含物定位于线粒体损伤区域和噬线粒体小泡,表明它们在线粒体毒性、诱导噬线粒体作用以及与受损线粒体片段一起清除方面的作用。几种 MAPK 可能协同作用以磷酸化 tau,特别是 JNK、p38 和 GSK3β,一种非 MAPK,也在 pα-突触核蛋白*/ptau 包含物附近被发现磷酸化。这些结果增加了对 pα-突触核蛋白发挥其毒性作用的机制的了解,包括 MAPK 途径的几种激酶的磷酸化,以及在线粒体膜上形成 ptau,可能导致线粒体毒性。因此,pα-突触核蛋白似乎是一系列激酶介导的致病事件的触发因素,也是α-突触核蛋白病理与 tau 之间的联系,tau 是另一种已知在帕金森病和其他突触核蛋白病中聚集的蛋白质。

相似文献

1
Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria.α-突触核蛋白的促线粒体毒性与 MAPK 激活有关,涉及到线粒体中 tau 的磷酸化和聚集。
Neurobiol Dis. 2019 Apr;124:248-262. doi: 10.1016/j.nbd.2018.11.015. Epub 2018 Nov 22.
2
Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.鉴定一种在帕金森病中诱导线粒体损伤和自噬的高度神经毒性α-突触核蛋白。
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2634-E2643. doi: 10.1073/pnas.1713849115. Epub 2018 Feb 27.
3
Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils.利用预先形成的 α-突触核蛋白淀粉样纤维在器官型脑切片培养物中模拟 α-突触核蛋白病。
J Parkinsons Dis. 2020;10(4):1397-1410. doi: 10.3233/JPD-202026.
4
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.α-突触核蛋白寡聚体诱导人 iPSC 为基础的突触核蛋白病模型中的早期轴突功能障碍。
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):7813-7818. doi: 10.1073/pnas.1713129115. Epub 2018 Jul 10.
5
GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.糖原合成酶激酶-3β(GSK-3β)失调会导致帕金森氏症样病理生理过程,伴有tau蛋白和α-突触核蛋白的区域特异性磷酸化及积累。
Cell Death Differ. 2015 May;22(5):838-51. doi: 10.1038/cdd.2014.179. Epub 2014 Nov 14.
6
Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.帕金森病和路易体痴呆中活性磷酸化依赖性丝裂原活化蛋白激酶(MAPK/ERK)、应激激活蛋白激酶/c-Jun氨基末端激酶(SAPK/JNK)和p38激酶的表达
J Neural Transm (Vienna). 2001;108(12):1383-96. doi: 10.1007/s007020100015.
7
Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.α-突触核蛋白和tau 与线粒体功能障碍的关联更新:对帕金森病的影响。
Eur J Neurosci. 2021 May;53(9):2946-2959. doi: 10.1111/ejn.14699. Epub 2020 Feb 25.
8
Alpha-Synuclein deficiency ameliorates chronic methamphetamine induced neurodegeneration in mice.α-突触核蛋白缺失可改善慢性甲基苯丙胺诱导的小鼠神经退行性变。
Toxicology. 2020 May 30;438:152461. doi: 10.1016/j.tox.2020.152461. Epub 2020 Apr 9.
9
Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.α-突触核蛋白种子诱导细胞内 tau 聚集,并为 tau 的过度磷酸化提供新的见解。
J Neurosci. 2011 May 25;31(21):7604-18. doi: 10.1523/JNEUROSCI.0297-11.2011.
10
Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage.中风后α-突触核蛋白的诱导介导缺血性脑损伤。
J Neurosci. 2016 Jun 29;36(26):7055-65. doi: 10.1523/JNEUROSCI.1241-16.2016.

引用本文的文献

1
The Characteristics of the Metabolomic Profile in Patients with Parkinson's Disease and Vascular Parkinsonism.帕金森病和血管性帕金森综合征患者的代谢组学特征
Acta Naturae. 2024 Oct-Dec;16(4):27-37. doi: 10.32607/actanaturae.27511.
2
Loss of O-GlcNAcylation modulates mTORC1 and autophagy in β cells, driving diabetes 2 progression.O-连接的N-乙酰葡糖胺糖基化修饰的缺失会调节β细胞中的mTORC1和自噬,推动2型糖尿病的进展。
JCI Insight. 2024 Dec 6;9(23):e183033. doi: 10.1172/jci.insight.183033.
3
Mitophagy Upregulation Occurs Early in the Neurodegenerative Process Mediated by α-Synuclein.
α-突触核蛋白介导的神经退行性过程中早期发生线粒体自噬上调。
Mol Neurobiol. 2024 Nov;61(11):9032-9042. doi: 10.1007/s12035-024-04131-6. Epub 2024 Apr 6.
4
Mechanisms of NURR1 Regulation: Consequences for Its Biological Activity and Involvement in Pathology.NURR1 调节机制:对其生物学活性及在病理学中作用的影响。
Int J Mol Sci. 2023 Jul 31;24(15):12280. doi: 10.3390/ijms241512280.
5
Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review.神经退行性疾病中轴突运输缺陷的常见潜在机制:一篇综述短文
Front Mol Neurosci. 2023 Apr 24;16:1172197. doi: 10.3389/fnmol.2023.1172197. eCollection 2023.
6
Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study.α-突触核蛋白聚集的细胞模型:我们学到了什么及对未来研究的启示
Biomedicines. 2022 Oct 20;10(10):2649. doi: 10.3390/biomedicines10102649.
7
Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity.重新审视磷酸化丝氨酸129抗体捕捉α-突触核蛋白生化和病理多样性的特异性及能力。
NPJ Parkinsons Dis. 2022 Oct 20;8(1):136. doi: 10.1038/s41531-022-00388-7.
8
Rose Bengal inhibits β-amyloid oligomers-induced tau hyperphosphorylation via acting on Akt and CDK5 kinases.玫瑰红 Bengal 通过作用于 Akt 和 CDK5 激酶抑制β-淀粉样蛋白寡聚物诱导的 tau 过度磷酸化。
Psychopharmacology (Berl). 2022 Nov;239(11):3579-3593. doi: 10.1007/s00213-022-06232-3. Epub 2022 Oct 12.
9
PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy.PTEN诱导的假定激酶1功能障碍加速突触核蛋白病。
J Parkinsons Dis. 2022;12(4):1201-1217. doi: 10.3233/JPD-213065.
10
Characterization of a Novel Monoclonal Antibody for Serine-129 Phosphorylated α-Synuclein: A Potential Application for Clinical and Basic Research.一种针对丝氨酸129磷酸化α-突触核蛋白的新型单克隆抗体的特性:在临床和基础研究中的潜在应用
Front Neurol. 2022 Feb 17;13:821792. doi: 10.3389/fneur.2022.821792. eCollection 2022.